What is Iya Med?
IYA Medical operates at the intersection of advanced medical technology and patient-centric care, specializing in minimally invasive procedures that redefine traditional surgical recovery timelines. By leveraging sophisticated techniques such as angiography, cryoablation, and uterine fibroid embolization, the company provides high-acuity care for conditions ranging from peripheral artery disease to complex oncological interventions. Based in the Scottsdale and Phoenix metropolitan areas, IYA Medical distinguishes itself through a model of same-day outpatient treatment, which significantly reduces the burden on hospital infrastructure while improving patient outcomes. Their board-certified team utilizes state-of-the-art imaging and procedural tools to ensure precision, positioning the firm as a leader in the regional healthcare market.
How much funding has Iya Med raised?
Iya Med has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Iya Med
PPP
Public-Private Partnership
What's next for Iya Med?
With the recent influx of capital, IYA Medical is well-positioned to accelerate its growth strategy, focusing on the integration of next-generation diagnostic tools and the expansion of its specialized clinical staff. The firm is expected to leverage this financial backing to enhance its outpatient facility infrastructure, thereby increasing patient throughput without compromising the high standard of care that has defined its reputation. As the healthcare industry shifts toward value-based care models, IYA Medical's focus on minimally invasive, cost-effective interventions provides a robust foundation for long-term sustainability. Future initiatives will likely prioritize the adoption of emerging medical technologies and the potential scaling of their service model into adjacent geographic markets, ensuring that the company remains at the forefront of interventional medicine.
See full Iya Med company page
